Identification and characterization of modified antisense oligonucleotides targeting DMPK in mice and nonhuman primates for the treatment of myotonic dystrophy type 1. [electronic resource]
- The Journal of pharmacology and experimental therapeutics Nov 2015
- 329-40 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural